Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferons in the therapy of solid tumors

S S Agarwala1, J M Kirkwood

  • 1Division of Medical Oncology, Pittsburgh Cancer Institute, University of Pittsburgh Medical Center, PA 15213-2592.

Oncology
|March 1, 1994
PubMed
Summary

Interferons show promise in treating solid tumors, particularly melanoma. Further research is exploring their combination with other therapies to enhance cancer treatment effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-year survival with tebentafusp in metastatic uveal melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Challenges and opportunities of predicting overall survival benefit from improvements to recurrence-free survival in stage II/III melanoma: a correlation meta-analysis.

Immuno-oncology technology·2025
Same author

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Reply to the letters to the editor 'Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma' by Schilling et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Targeting the MAPK pathway in advanced BRAF wild-type melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Psychosocial impact of skin biopsies in the setting of melanoma screening: a cross-sectional survey.

The British journal of dermatology·2018

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Interferons are natural proteins with significant immunological properties.
  • Recombinant DNA technology enables large-scale production of purified interferons for clinical research.
  • Interferons are being investigated for their anti-cancer potential across various tumor types.

Purpose of the Study:

  • To review the current applications of interferons in treating solid tumors.
  • To highlight the efficacy of Interferon-alpha in specific cancer types.
  • To discuss the future directions for interferon-based cancer therapies.

Main Methods:

  • Review of existing literature on interferon therapy for solid tumors.
  • Analysis of clinical data regarding Interferon-alpha efficacy.
  • Exploration of combination therapies involving interferons.

Main Results:

  • Interferon-alpha has shown encouraging results in treating melanoma, a nonhematological neoplasm.
  • Locoregional interferon treatment has demonstrated effectiveness in other tumor types.
  • The study provides a comprehensive overview of interferons' role in solid tumor treatment.

Conclusions:

  • Interferons, especially Interferon-alpha, represent a valuable therapeutic option for certain solid tumors.
  • Combination therapies with chemotherapy and other immunomodulators may enhance interferon efficacy.
  • Continued research is crucial to fully understand and optimize the therapeutic role of interferons in oncology.

Related Experiment Videos